You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
| Title |
Self-Reported quality of life in adults with attention-deficit/hyperactivity disorder and executive function impairment treated with lisdexamfetamine dimesylate: a randomized, double-blind, multicenter, placebo-controlled, parallel-group study
|
|---|---|
| Published in |
BMC Psychiatry, October 2013
|
| DOI | 10.1186/1471-244x-13-253 |
| Pubmed ID | |
| Authors |
Lenard A Adler, Bryan Dirks, Patrick Deas, Aparna Raychaudhuri, Matthew Dauphin, Keith Saylor, Richard Weisler |
| Abstract |
This study examined the effects of lisdexamfetamine dimesylate (LDX) on quality of life (QOL) in adults with attention-deficit/hyperactivity disorder (ADHD) and clinically significant executive function deficits (EFD). |
Mendeley readers
The data shown below were compiled from readership statistics for 129 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 2% |
| Brazil | 1 | <1% |
| Unknown | 126 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 21 | 16% |
| Student > Ph. D. Student | 14 | 11% |
| Student > Master | 13 | 10% |
| Student > Postgraduate | 10 | 8% |
| Student > Doctoral Student | 8 | 6% |
| Other | 28 | 22% |
| Unknown | 35 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Psychology | 31 | 24% |
| Medicine and Dentistry | 29 | 22% |
| Neuroscience | 6 | 5% |
| Social Sciences | 4 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 3% |
| Other | 15 | 12% |
| Unknown | 40 | 31% |